- $871.97m
- $2.41bn
- $257.74m
- 73
- 59
- 78
- 79
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 233 | 230 | 240 | 246 | 258 |
Cost of Revenue | |||||
Gross Profit | 175 | 172 | 178 | 181 | 191 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 168 | 180 | 178 | 180 | 189 |
Operating Profit | 64.6 | 50 | 61.6 | 65.4 | 69 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 64.2 | 50.3 | 61.6 | 65.4 | 69 |
Net Income After Taxes | 64.2 | 50.3 | 61.6 | 65.4 | 69 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 51.7 | 40.4 | 48.4 | 50.2 | 52.7 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 36.3 | 29.2 | 37.2 | 39 | 41.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.57 | 1.24 | 1.57 | 1.65 | 1.73 |
Dividends per Share |